CytoDyn Inc. Quarterly Common Stock, Value, Issued in USD from Q2 2011 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary
CytoDyn Inc. quarterly Common Stock, Value, Issued history and growth rate from Q2 2011 to Q4 2024.
  • CytoDyn Inc. Common Stock, Value, Issued for the quarter ending November 30, 2024 was $1.22M, a 26.1% increase year-over-year.
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $1.22M +$253K +26.1% Nov 30, 2024 10-Q 2025-01-14
Q3 2024 $1.22M +$289K +31% Aug 31, 2024 10-Q 2024-10-15
Q2 2024 $1.06M +$140K +15.2% May 31, 2024 10-Q 2025-01-14
Q1 2024 $990K +$153K +18.3% Feb 29, 2024 10-Q 2024-04-15
Q4 2023 $971K +$146K +17.7% Nov 30, 2023 10-Q 2024-01-16
Q3 2023 $931K +$118K +14.5% Aug 31, 2023 10-Q 2023-10-23
Q2 2023 $919K +$199K +27.6% May 31, 2023 10-K 2024-08-15
Q1 2023 $837K +$124K +17.4% Feb 28, 2023 10-Q 2023-04-10
Q4 2022 $825K +$139K +20.3% Nov 30, 2022 10-Q 2023-01-09
Q3 2022 $813K +$169K +26.2% Aug 31, 2022 10-Q/A 2022-10-13
Q2 2022 $720K +$94K +15% May 31, 2022 10-K 2023-09-14
Q1 2022 $713K +$104K +17.1% Feb 28, 2022 10-Q 2022-04-11
Q4 2021 $686K +$96K +16.3% Nov 30, 2021 10-Q 2022-01-10
Q3 2021 $644K +$74K +13% Aug 31, 2021 10-Q 2021-10-12
Q2 2021 $626K +$107K +20.6% May 31, 2021 10-K 2022-08-15
Q1 2021 $609K +$138K +29.3% Feb 28, 2021 10-Q 2021-04-14
Q4 2020 $590K +$191K +47.8% Nov 30, 2020 10-Q 2021-01-08
Q3 2020 $570K +$186K +48.6% Aug 31, 2020 10-Q 2020-10-09
Q2 2020 $519K +$189K +57.5% May 31, 2020 10-K 2021-07-30
Q1 2020 $471K +$166K +54.6% Feb 29, 2020 10-Q 2020-04-09
Q4 2019 $399K +$109K +37.3% Nov 30, 2019 10-Q 2020-01-09
Q3 2019 $384K +$150K +64% Aug 31, 2019 10-Q 2019-10-08
Q2 2019 $330K +$113K +52% May 31, 2019 10-K 2020-08-14
Q1 2019 $305K +$95.8K +45.8% Feb 28, 2019 10-Q 2019-04-09
Q4 2018 $291K +$126K +76.1% Nov 30, 2018 10-Q 2019-01-09
Q3 2018 $234K +$81.1K +53.1% Aug 31, 2018 10-Q 2018-10-09
Q2 2018 $217K +$67.4K +45.1% May 31, 2018 10-K 2019-08-14
Q1 2018 $209K +$59.4K +39.8% Feb 28, 2018 10-Q 2018-04-09
Q4 2017 $165K +$26.9K +19.5% Nov 30, 2017 10-Q 2018-01-08
Q3 2017 $153K +$27.9K +22.3% Aug 31, 2017 10-Q 2017-10-10
Q2 2017 $149K +$26.1K +21.2% May 31, 2017 10-K 2018-07-27
Q1 2017 $149K +$31.1K +26.3% Feb 28, 2017 10-Q 2017-04-13
Q4 2016 $138K +$47.2K +51.8% Nov 30, 2016 10-Q 2017-01-13
Q3 2016 $125K +$45.3K +56.9% Aug 31, 2016 10-Q 2016-10-12
Q2 2016 $123K +$59.7K +93.8% May 31, 2016 10-K 2017-07-20
Q1 2016 $118K -$32.5M -99.6% Feb 29, 2016 10-Q 2016-04-13
Q4 2015 $91.1K -$32.2M -99.7% Nov 30, 2015 10-Q 2016-01-11
Q3 2015 $79.6K -$30.3M -99.7% Aug 31, 2015 10-Q 2015-10-09
Q2 2015 $63.6K -$30.3M -99.8% May 31, 2015 10-K 2016-07-19
Q1 2015 $32.6M +$2.16M +7.1% Feb 28, 2015 10-Q 2015-04-10
Q4 2014 $32.3M +$2.01M +6.63% Nov 30, 2014 10-Q 2015-01-12
Q3 2014 $30.4M +$13.2M +76.8% Aug 31, 2014 10-Q 2014-10-10
Q2 2014 $30.4M +$14.2M +88.1% May 31, 2014 10-K 2015-07-10
Q1 2014 $30.4M +$14M +85.3% Feb 28, 2014 10-Q 2014-04-11
Q4 2013 $30.3M +$14.5M +91.2% Nov 30, 2013 10-Q 2014-01-13
Q3 2013 $17.2M +$1.26M +7.9% Aug 31, 2013 10-Q 2013-10-15
Q2 2013 $16.1M +$994K +6.56% May 31, 2013 10-K 2014-07-10
Q1 2013 $16.4M +$1.62M +10.9% Feb 28, 2013 10-Q 2013-04-12
Q4 2012 $15.9M +$6.81M +75.3% Nov 30, 2012 10-Q 2013-01-14
Q3 2012 $15.9M +$6.77M +74% Aug 31, 2012 10-Q/A 2012-11-08
Q2 2012 $15.2M +$6M +65.6% May 31, 2012 10-K 2013-08-29
Q1 2012 $14.8M Feb 29, 2012 10-Q 2012-04-16
Q4 2011 $9.04M Nov 30, 2011 10-Q 2012-01-17
Q3 2011 $9.15M Aug 31, 2011 10-Q/A 2011-11-30
Q2 2011 $9.15M May 31, 2011 10-K 2012-08-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.